The Board of Novax has appointed Jonas Hedman as permanent CEO, following his role as interim CEO since September. Novax is Axel Johnson’s investment company, with a clear mission to build significant future businesses for the Axel Johnson Group.
Jonas Hedman joined Novax in 2016 as Senior Director and has since played a central role in the company’s development. He currently represents Novax as Chairman of the Board of Personalkollen and as a Board Member of Apohem, Medovia, Bond Health Group, RCO and Voyado.
Anders Slettengren, Chairman of the board of Novax, comments:
“Jonas has demonstrated through both strong results and leadership that he is the right person to lead Novax going forward. He is clear, accountable and guided by strong values. I look forward to working together with Jonas and the rest of the team to further develop the Novax portfolio into an important part of Axel Johnson’s future.”
Jonas Hedman, CEO of Novax, says:
“I am both honoured and inspired to continue leading Novax. I firmly believe that the best results are achieved through teamwork, strong expertise and clear ambitions – paired with a business mindset that combines performance with heart. Together with our companies, we will continue to build strong platforms and new growth journeys that create long-term value for customers, employees and Axel Johnson.”
About Novax
Novax is an active, long-term ownership partner investing in small and mid-sized growth companies. Today, Novax has several platform companies, most of which generate annual revenues of around SEK 1 billion. These include the health and fitness group Bond Health Group, with STC gyms and Bruce’s digital platform; the growing European ingredients group Ingå Group; Latend, which includes Aqua Dental in dental care; Apohem, jointly owned with Axfood; and RCO, operating in technical security and access control.
In addition, Novax is the majority owner of several smaller growth companies with the potential to develop into future platform companies, including Personalkollen, Onelab and Muntra.
